Thomas J. Bollyky (Council on Foreign Relations) joins to explain the problems facing the US pharmaceutical market, the Trump administration's new tariffs and pricing deal with the United Kingdom, and the impact on American drug… Read more

Aime Williams (Financial Times) joins Chad Bown to help explain what has happened since President Trump’s sweeping April 2, 2025 tariff announcement. They discuss the surprises in the US import and export data from 2025,… Read more